J. Carmichael
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
-
- Ovarian cancer diagnosis and treatment 9
- Oncology 14
- PARP inhibition in cancer therapy 10
- Co-authors
- Michael FriedländerM. William AudehAndrew TuttJeffrey N. WeitzelJudy E. GarberMark E. RobsonAdrian L. HarrisSusan M. Domchek
- Journals
- Journal of Clinical Oncology (12 papers)British Journal of Cancer (5 papers)Clinical Anatomy (1 paper)Gynecologic Oncology (1 paper)BMJ (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
J. Carmichael
24 papers receiving 940 citations
Peers
Comparison fields: 5 of 63
- Reproductive Medicine 374
- Oncology 635
- Obstetrics and Gynecology 97
- Cancer Research 178
- Pathology and Forensic Medicine 128
Countries citing papers authored by J. Carmichael
This map shows the geographic impact of J. Carmichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Carmichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Carmichael more than expected).
Fields of papers citing papers by J. Carmichael
This network shows the impact of papers produced by J. Carmichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Carmichael. The network helps show where J. Carmichael may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Carmichael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 5 | |
| 2 | 2011 | 48 | |
| 3 | PHASE II STUDY OF THE ORAL PARP INHIBITOR OLAPARIB (AZD2281) VERSUS LIPOSOMAL DOXORUBICIN IN OVARIAN CANCER PATIENTS WITH BRCA1 AND/OR BRCA2 MUTATIONS | 2010 | 21 |
| 4 | 2010 | 12 | |
| 5 | 2010 | 51 | |
| 6 | 2009 | 141 | |
| 7 | 2009 | 98 | |
| 8 | 2009 | 18 | |
| 9 | 2009 | 82 | |
| 10 | 1997 | 19 | |
| 11 | A phase II trial of epirubicin plus paclitaxel in metastatic breast cancer. United Kingdom Coordinating Committee for Cancer Research Breast Cancer Sub-Committee. | 1997 | 7 |
| 12 | 1993 | 14 | |
| 13 | 1992 | 52 | |
| 14 | 1992 | 23 | |
| 15 | 1992 | 155 | |
| 16 | 1991 | 12 | |
| 17 | 1989 | 38 | |
| 18 | 1988 | 65 | |
| 19 | 1988 | 11 | |
| 20 | High-dose-intensity regimen of weekly doxorubicin and cisplatin in the treatment of patients with stage III and IV epithelial ovarian carcinoma. | 1987 | 3 |
About J. Carmichael
J. Carmichael is a scholar working on Reproductive Medicine, Oncology, Genetics, Internal Medicine and Cancer Research, having authored 24 papers that have together received 987 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), Ovarian cancer diagnosis and treatment (9 papers), BRCA gene mutations in cancer (8 papers), Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (2 papers), Estrogen and related hormone effects (2 papers), Cancer Genomics and Diagnostics (2 papers) and Chemotherapy-induced organ toxicity mitigation (1 paper). The work is most often cited by research in Reproductive Medicine (374 citations), Oncology (635 citations), Obstetrics and Gynecology (97 citations), Cancer Research (178 citations) and Pathology and Forensic Medicine (128 citations). J. Carmichael has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Michael Friedländer, M. William Audeh, Andrew Tutt, Jeffrey N. Weitzel, Judy E. Garber, Mark E. Robson, Adrian L. Harris, Susan M. Domchek, B.M.J. Cantwell and Moni Roy. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Anatomy, Gynecologic Oncology and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.